Combination of Sanguisorbigenin and Conventional Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus: Inhibition of Biofilm Formation and Alteration of Cell Membrane Permeability

Methicillin-resistant Staphylococcus aureus (MRSA) infection is challenging to eradicate because of antibiotic resistance and biofilm formation. Novel antimicrobial agents and alternative therapies are urgently needed. This study aimed to evaluate the synergy of sanguisorbigenin (SGB) isolated from...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shu, Liu, Xiang-Qian, Kang, Ok-Hwa, Kwon, Dong-Yeul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032919/
https://www.ncbi.nlm.nih.gov/pubmed/35457049
http://dx.doi.org/10.3390/ijms23084232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032919/
https://www.ncbi.nlm.nih.gov/pubmed/35457049
http://dx.doi.org/10.3390/ijms23084232

Ejemplares similares